title: Tumour-selective Salmonella-based cancer therapy.
authors.affiliation: Vion Pharmaceuticals, Inc., 4 Science Park, New Haven, CT 06511, USA. DBermude@Vionpharm.com
authors.forename: D
authors.initials: D
authors.lastname: Bermudes
authors.forename: K B
authors.initials: KB
authors.lastname: Low
authors.forename: J
authors.initials: J
authors.lastname: Pawelek
authors.forename: M
authors.initials: M
authors.lastname: Feng
authors.forename: M
authors.initials: M
authors.lastname: Belcourt
authors.forename: L M
authors.initials: LM
authors.lastname: Zheng
authors.forename: I
authors.initials: I
authors.lastname: King
mesh_terms: D000818:Animals; D015316:Genetic Therapy; D006801:Humans; D016296:Mutagenesis; D009369:Neoplasms / Q000188:drug therapy*; D012475:Salmonella / Q000235:genetics*; D014183:Transplantation, Heterologous